MRD in PAAD Adjuvant Therapy

Clinical trial NCT06867146 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06867146
Sponsor: Peking Union Medical College Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy Molecular Residual Disease Pancreatic Cancer Adjuvant Therapy

Start date: 2024-10-15
Primary completion: 2026-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.